Regulatory PathRegulatory requirements compared

Active substances

Estradiol + Norethisterone

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
ESTRACOMB TTS PATCHESCutaneous patch · Transdermal use4 BoxSAR 56.50Generic · PrescriptionNOVARTISWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
COMBIPATCH0.05MG/24HR;0.14MG/24HR; 0.05MG/24HR;0.25MG/24HRfilm, extended release · transdermalNOVEN PHARMS INCPrescription7 Aug 1998
ACTIVELLA1MG;0.5MGtablet · oralAMNEALPrescription18 Nov 1998
ACTIVELLA1MG/0.5MGtablet · oralNOVO NORDISK INCPrescription29 Dec 2006
ESTRADIOL AND NORETHINDRONE ACETATE1MG;0.5MG; 0.5MG;0.1MGtablet · oralBRECKENRIDGE PHARMPrescription17 Apr 2008
ESTRADIOL AND NORETHINDRONE ACETATE1MG;0.5MGtablet · oralBARRPrescription11 May 2010
AMABELZ0.5MG;0.1MG; 1MG;0.5MGtablet · oralLUPINPrescription20 Jun 2016
ESTRADIOL AND NORETHINDRONE ACETATE0.5MG;0.1MG; 1MG;0.5MGtablet · oralXIROMEDPrescription10 Feb 2017
ESTRADIOL AND NORETHINDRONE ACETATE1MG;0.5MGtablet · oralNAARI PTEPrescription28 Feb 2018
ESTRADIOL AND NORETHINDRONE ACETATE0.5MG;0.1MG; 1MG;0.5MGtablet · oralNOVAST LABSPrescription3 Apr 2019
ACTIVELLA0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralAMNEALDiscontinued18 Nov 1998
ACTIVELLA1MG/0.5MGtablet · oralNOVO NORDISKDiscontinued11 Apr 2000
ESTRADIOL AND NORETHINDRONE ACETATE0.5MG;0.1MGtablet · oralTEVA PHARMS USADiscontinued8 Mar 2012
ETYQA0.5MG;0.1MG; 1MG;0.5MGtablet · oralAUROBINDO PHARMA LTDDiscontinued30 Jun 2023

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
ACTIVELLE022494050.5 MG; 1 MGTABLET · ORALNOVO NORDISK CANADA INC
ACTIVELLE LD023090090.5 MG; 0.1 MGTABLET · ORALNOVO NORDISK CANADA INC
ESTALIS 140/50 MCG02241835140 MCG / 24 HOUR; 50 MCG / 24 HOURPATCH · TRANSDERMALSANDOZ CANADA INCORPORATED
ESTALIS 250/50 MCG02241837250 MCG / 24 HOUR; 50 MCG / 24 HOURPATCH · TRANSDERMALSANDOZ CANADA INCORPORATED

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACCOMBIPATCH 0.05-0.14 MG PTCH$31.83617per EA23 Sep 2026
US NADACCOMBIPATCH 0.05-0.25 MG PTCH$31.7862per EA23 Sep 2026
NHS Drug TariffEstradiol 1mg / Norethisterone acetate 500microgram tablets£13.2084 tablet1 Oct 2026
NHS Drug TariffEstradiol 2mg / Norethisterone acetate 1mg tablets£17.0284 tablet1 Oct 2026
NHS Drug TariffEstradiol 30micrograms/24hours / Norethisterone 95micrograms/24hours transdermal patches£15.468 patch1 Oct 2026
NHS Drug TariffEstradiol 30micrograms/24hours / Norethisterone 95micrograms/24hours transdermal patches£44.2724 patch1 Oct 2026
NHS Drug TariffEstradiol 40micrograms/24hours / Norethisterone 130micrograms/24hours transdermal patches£15.468 patch1 Oct 2026
NHS Drug TariffEstradiol 40micrograms/24hours / Norethisterone 130micrograms/24hours transdermal patches£44.2724 patch1 Oct 2026
NHS Drug TariffEstradiol 50micrograms/24hours / Norethisterone 170micrograms/24hours transdermal patches£44.2824 patch1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.